Prognostic assessment of breast carcinoma submitted to neoadjuvant chemotherapy with pathological non-complete response

Table 3 Recurrence risk of non-pCR carcinoma according to Clustered Neo-Bioscore

Clustered Neo-Bioscore	mTFR^a (days)	p	HR^b (CI95%)
Low	1388	Reference
Low-intermediate	1247	< 0.01	2.61 (1.33–5.11)
High-intermediate	618	< 0.01	14.05 (6.78–29.11)
High	433	< 0.01	22.19 (7.70–63.92)

ISSN: 1471-2407